Merck KGaA (OTCMKTS:MKKGY) Reaches New 52-Week Low – What’s Next?

Merck KGaA (OTCMKTS:MKKGY) shares reached a new 52-week low on Tuesday . The stock traded as low as $27.13 and last traded at $27.23, with a volume of 216038 shares changing hands. The stock had previously closed at $27.42.

Merck KGaA Trading Down 0.7 %

The company has a debt-to-equity ratio of 0.28, a current ratio of 1.33 and a quick ratio of 0.91. The stock’s 50-day moving average is $29.09 and its two-hundred day moving average is $30.82. The company has a market cap of $17.60 billion, a P/E ratio of 16.81, a P/E/G ratio of 2.05 and a beta of 0.98.

Merck KGaA (OTCMKTS:MKKGY) last released its quarterly earnings results on Thursday, March 6th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.07. The firm had revenue of $5.78 billion for the quarter, compared to the consensus estimate of $5.40 billion. Merck KGaA had a return on equity of 10.41% and a net margin of 12.89%. As a group, equities research analysts predict that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.